Hi, I've got several families (trios, looking for denovos) where another sibling has also been sequenced. Can anyone suggest some good options for using these extra individuals?
thanks.
thanks.
-
-
We're rarely looking for de novo's in that situation if we have larger families, but in this case I'd be using the extra sib as a subtractive screen (if unaffected) or looking for the same de novo in both (if affected).Originally posted by Elsie View Post
Seeing as there are so few de novo mutations (certainly in exomes which is what we generally do) this may not be entirely cost effective. But when you have a suspected recessive in a consanguineous family and you have either another affected or unaffected sib it can really reduce the search space. -
You can use the extra genotyped individual to add information. For example you can use kggseq with a recessive study option:
java -jar ./kggseq.jar --buildver hg19 --vcf-file path/to/file1 --ped-file path/to/file2 --genotype-filter 1
Filter out variants for which their genotypes are not consistent with the assumption of disease inheritance pattern.
Functions and applicable models for each code of '--genotype-filter'options are listed below:
Code Function Applicable model
1 Exclude variants at which affected subjects have heterozygous genotypes. RecessiveComment
-
Hello,
I've written a small program for annotating inheritance patterns in arbitrary pedigrees, it might be of some help.
Check out https://github.com/moonso/genmod
Good luck!Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment